Predicting gene promoter methylation in non-small-cell lung cancer by evaluating sputum and serum

The use of 5-methylcytosine demethylating agents in conjunction with inhibitors of histone deacetylation may offer a new therapeutic strategy for lung cancer. Monitoring the efficacy of gene demethylating treatment directly within the tumour may be difficult due to tumour location. This study determ...

Descripción completa

Detalles Bibliográficos
Autores principales: Belinsky, S A, Grimes, M J, Casas, E, Stidley, C A, Franklin, W A, Bocklage, T J, Johnson, D H, Schiller, J H
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Genetics and Genomics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360148/
https://www.ncbi.nlm.nih.gov/pubmed/17406356
http://dx.doi.org/10.1038/sj.bjc.6603721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360148/
https://www.ncbi.nlm.nih.gov/pubmed/17406356
http://dx.doi.org/10.1038/sj.bjc.6603721

Ejemplares similares